Empowering Pharma Innovation, Molecule by Molecule.
Delivering Quality. Enabling Progress.
At Survival Technologies Pvt. Ltd., we are dedicated to supporting the pharmaceutical industry through the development and supply of high-quality specialty chemicals, advanced intermediates, and custom synthesis solutions. Our deep technical expertise and commitment to innovation make us a trusted partner to leading pharmaceutical manufacturers across the globe.
Driving Innovation in Pharmaceutical Chemistry
With decades of experience in complex chemical synthesis, we specialize in delivering reliable intermediates and fine chemicals that serve as essential building blocks for Active Pharmaceutical Ingredients (APIs) and advanced formulations. Each product is developed with precision, ensuring the highest standards of purity, stability, and performance.
Our Capabilities
Custom Synthesis
Tailor-made solutions to meet specific molecular requirements.
Pharma Intermediates
High-purity intermediates that adhere to global pharmaceutical standards.
Process Development & Scale-Up
Expertise in scaling lab innovations to commercial production.
GMP-Compliant Manufacturing
Facilities equipped to maintain safety, consistency, and regulatory compliance.
Commitment to Quality and Compliance
Quality is at the core of everything we do. Our operations follow Good Manufacturing Practices (GMP) and are backed by a robust Quality Assurance and Quality Control (QA/QC) framework. We ensure full traceability, documentation, and testing at every stage to meet international regulatory expectations.
Partnering for a Healthier Tomorrow
We understand that the pharmaceutical industry demands not just precision but reliability and partnership. At Survival Technologies, we work closely with our clients to provide cost-effective, high-performance, and sustainable chemical solutions that help accelerate drug discovery, development, and production. Through chemistry that empowers progress, we enable pharmaceutical innovation — safely, efficiently, and responsibly.